Navigation Links
Mining for gems in the fungal genome

secondary metabolites in that species continued. Although scientists were able to pinpoint the locations of genes believed to be involved in the production of secondary metabolites by pouring over the sequence data, the actual activity of the genes and their gene products still needed to be confirmed.

The method developed by Keller and her colleagues solves this problem and promises to broaden the search for medically useful agents by taking a powerful, genome-wide approach. Their technique is called "genomic mining" because of its robust ability to dig through an entire fungal genome to locate nearly all the hidden gems-the actively-produced secondary metabolites-at once.

The key to Keller's approach lies in a single fungal protein called LaeA. A few years ago, her team discovered that the presence of LaeA is required to turn on the genes that manufacture secondary metabolites in Aspergillus nidulans. "LaeA controls the production of secondary metabolites," says Keller.

For some as-yet unknown biological reason, all the genes required for the production of any given secondary metabolite-usually between three and two dozen genes-are located right next to each other along the chromosome in a gene cluster. These groups of genes stand out in certain scientific analyses, making secondary metabolite gene clusters easy to spot. Keller capitalized on these facts to find actively-produced secondary metabolites.

In one experiment, Jin Woo Bok, a research scientist in Keller's lab and co-author on the paper, deleted the LaeA gene in Aspergillus nidulans. Using a device called a microarray, the research team measured the activity of every gene in the LaeA-free mutant. "We looked at the entire 10,000 genes in this fungus," says Keller.

Keller's team searched the genome for groups of contiguous genes that were inactive in the mutant. They knew these were very likely to be gene clusters involved in the production of seco
'"/>

Source:University of Wisconsin-Madison


Page: 1 2 3

Related biology news :

1. Mining biotechs data mother lode
2. Light therapy may combat fungal infections, new evidence suggests
3. Symbiotic bacteria protect hunting wasps from fungal infestation
4. CO2 sensing proves critical for fungal pathogens to adapt to life in air and human hosts
5. Pillows - a hot bed of fungal spores
6. Genetic defenders protect crops from fungal disease
7. New method enables gene disruption in destructive fungal pathogen
8. U of M researchers discover genetic key to treating deadly fungal infections
9. Tearing down the fungal cell wall
10. Anti-fungal drug stops blood vessel growth
11. Antifungal drug kills TB bug

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mining for gems the fungal genome

(Date:11/23/2009)...ns like frogs and toads have existed for 360 milli...ut a new aquatic fungus is threatening to make man...November issue of Microbiology Today . , The f...found to be associated with waves of amphibian ext...ralia in the 1990,s. Bd infects over 350 amphibian...
(Date:11/23/2009)...study from Perth,s Telethon Institute for Child He...nd timing of alcohol consumption in pregnancy affe...dy has just been published online in the internati...O,Leary said the analysis was drawn from a random ...uestionnaire three months after the baby,s deliver...
(Date:11/23/2009)...erflows are a nasty business, posing dangers to hu...te University is launching a new project with fund...(EPA) that targets the fat and grease that contrib...give urban planners new tools to further reduce th...s from "sanitary" sewer systems, as opposed to "co...
Breaking Biology News(10 mins):New study links alcohol in pregnancy to child behavior problems 2Lose the fat: Targeting grease to curtail sewer overflows 23SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 13SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 23SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 33SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 43SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 53SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 63SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 73SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 83SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 93SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 103SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 113SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 123SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 133SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 143SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 153SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 163SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 173SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 183SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 193SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 203SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 213SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 223SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 233SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 243SBio Inc Announces Unaudited Second Quarter 2009 Results 54264 25HeartWare to Present at Canaccord Adams 29th Annual Global Growth Conference 54260 1Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors 54259 1Webmedx Announces That CEO Sean Carroll Has Been Appointed to the AHIMA Foundation Board of Directors 54259 2
... a GSK company focused on discovering and developi... such as Type 2 Diabetes, announced today that it ... of sirtuin research and its potential to treat di...rial disorders, inflammation, cancer, and heart di...ets to Treat Age-Associated Diseases," the review ...
...in the October 2008 issue of BioScience are as fol...st with a Molecular Master. , Kabir G. Peay, Pet...chniques have in recent years allowed the systemat...ime. Results show extremely high diversity and var...lanation for which is unknown. High-throughput DNA...
...ronmental benefit for shade-grown Latin American c...technique will provide a buffer against the ravage... the last three decades, many Latin American coffe... techniques, in which the plants are grown beneath...se production, much of the acreage has been conver...
Other Biology News:Sirtris' review of sirtuin therapeutics for diseases of aging in Nature Reviews Drug Discovery 2BioScience tip sheet, October 2008 2BioScience tip sheet, October 2008 3Green coffee-growing practices buffer climate-change impacts 2
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...,Who: David Appia, French Ambassador for Internati...t in France Agency, , , , ,What: Ambassador Appia... pro-business initiatives adopted by France to fur...ndscape for innovation and development., , ,When: ...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--Sigma-AldrichCorporati...ferenceonTuesday,December1stat1:45PMGMTinLondon,7:...roadcastovertheInternetavailableat http://inve s..."Webcast"icontoaccessthisfile. ,, AboutSigma-...hTechnologycompany.Itschemicalandbiochemicalproduc...
(Date:11/24/2009)...v.24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe...pprovedthe,investigationalnewdrugapplication(IND)f...informulationtotreatdiabetes.ThisIND,approvalallow..., Diabetesisadisordercharacteristicofhighbloodgl...oftenresultinseveremicro-and,macro-vasculardisease...
(Date:11/24/2009)...mber24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NA...ompany,today,announcedthatithassubmittedaMAAtotheE...pany,senzymereplacementtherapyindevelopment,forthe...ting,applicationforvelaglucerasealfathathasbeensub...dCanada. , Basedonaglobalsupplyshortageofthec...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3
...this is my last article of the year, and I have ta..., so my New Year,s resolution for this column is b...ck, or folk-related). Part of the problem is that ...st year, or bought many new CDs (something else I ...us has been more on biotech,s international side a...
...irst spot on Google , Yahoo , or MSN , all it u...xperts aren,t sure exactly what it,s going to take... pay-per click (PPC) infrastructures to increase t...duce the ranking for ads promoting link farms and .... , ,The benefits of these updates to search engin...
...s. - The nation,s space agency announced this mon... long enough to pack for the longer trip to Mars ...dministration should bypass the Earth,s lifeles...where there are tantalizing signs of water. Still ...siness of space flight and let private entrepreneu...
Other Biology Technology:2006: A great biotech financing year, unless you were going public! 22006: A great biotech financing year, unless you were going public! 32006: A great biotech financing year, unless you were going public! 42006: A great biotech financing year, unless you were going public! 5It takes more than money to reach the top 2It takes more than money to reach the top 3It takes more than money to reach the top 4Flying to the moon? Take Wisconsin tech along 2Flying to the moon? Take Wisconsin tech along 3Flying to the moon? Take Wisconsin tech along 4
Rabbit Anti-Human BAR Antibody, Unconjugated from CHEMICON
Anti-UbcH7 Antibody, Unconjugated from CHEMICON
Mouse Anti-Mouse TCR, DO11.10 Monoclonal Antibody, Biotin Conjugated, Clone KJ1-26 from CEDARLANE Laboratories Limited
Mouse Anti-5-Methylcytosine Monoclonal Antibody, Unconjugated, Clone 33D3 from Eurogentec
Biology Products: